ArticleFrontiers in molecular biosciences2023

AVEN: a novel oncogenic biomarker with prognostic significance and implications of AVEN-associated immunophenotypes in lung adenocarcinoma.

Dengxia Fan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.